RADiant is the best option for treating SCC in those patients for whom the surgery is not an option ( due to contraindications or personal preferences).
The American Academy of Dermatologist supports consideration of superficial radiation therapy as a second line option for the treatment of SCC, for use in special circumstances, such as when surgical intervention is contraindicated.
Benefits of radiation for SCC
RADiant is an effective alternative for patients who are not suitable candidates for surgery due to age, general health, or personal preferences.
Radiation therapy has outcomes comparable to Mohs micro surgery, with low complication rates and good to excellent cosmetic results.
Removes wound care concerns for patients with surgical contraindications.
RADiant may give a better cosmetic output – the disadvantage of surgical excision is the potential for disfigurement and functional defects when the cancer is located in high-risk areas such as the eyes nose and lips.
How it works
The primary goal for SCC is to cure or eliminate the lesion with no long term recurrence whilst preserving function in the region affected by cancer and optimising cosmetic outcomes.
Why use RADiant Therapy?
RADiant is designed to deliver eBt and/or SRT treatment techniques, which are well documented in the treatment of SCCs.
Treatment
Illuminated halo ring guidance allows for optimal conformal treatment positioning and ensures accurate dosimetry.
Benefits of the clinic
RADient enables your clinic to code to either eBt or SRT depending on the reimbursement policy of the patient insurance / Medicare provider.
